Diana Kraskouskaya is a CEO, co-founder, and board observer with experience in the pharmaceutical industry at Dalriada Drug Discovery and Dunad Therapeutics. Diana also has a background in research, education, and leadership roles at the University of Toronto and various organizations. Diana holds a PhD in Chemistry and a Bachelor's degree in Molecular Biology and Chemistry.